| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Division of Urology, Sunnybrook and Women’s College Health Sciences Centre, 2 University Health Network, 3 Department of Public Health Sciences, 4 Department of Pathology, 5 Department of Medical Imaging, University Health Network, University of Toronto, Toronto, Ontario, and 6 Department of Oncology, McGill University, Montreal, Quebec, Canada
We examined whether selected polymorphisms in 11 candidate genes and serum levels of insulin-like growth factor I (IGF-I) help predict the presence of prostate cancer among patients prescreened with prostate-specific antigen (PSA) and digital rectal exam (DRE). We studied 1031 consecutive men who underwent one or more prostate biopsies because of an elevated PSA level (>4 ng/ml) or an abnormal DRE. Eleven candidate genes were examined, including the androgen receptor, SRD5A2, CYP17, CYP3A4, vitamin D receptor, PSA, GST-T1, GST-M1, GST-P1, IGF-I, and IGF binding protein 3. We also measured serum IGF-I levels before biopsy. Of the 1031 men, 483 had cancer on any biopsy (cases) and 548 men had no cancer (controls). Age, ethnicity, total PSA, and DRE result were strongly predictive of the presence of prostate cancer. The mean IGF-I level for cases (119.4 ng/ml) was lower than for controls (124.4 ng/ml, P = 0.05) and were not predictive for the presence of prostate cancer. We found no associations between the androgen receptor, SRD5A2, CYP17, CYP3A4, vitamin D receptor, GST-M1, GST-P1, and IGF binding protein 3 genotypes and prostate cancer risk. The adjusted odds ratios for having prostate cancer for patients with the GST-T1 and IGF-I variant alleles were 1.64 (95% confidence interval, 1.1–2.4; P = 0.01) and 1.70 (95% confidence interval, 1.1–2.7; P = 0.02), respectively. Nine of 11 candidate genes were not significantly predictive for prostate cancer in a clinical setting. The GST-T1 and IGF-I polymorphisms demonstrated modest associations with prostate cancer risk. IGF-I levels were not helpful in identifying patients with prostate cancer at the time of biopsy.
This article has been cited by other articles:
|
|
 |
|
  R. K. Nam, W. W. Zhang, L. H. Klotz, J. Trachtenberg, M. A.S. Jewett, J. Sweet, A. Toi, S. Teahan, V. Venkateswaran, L. Sugar, et al. Variants of the hK2 Protein Gene (KLK2) Are Associated with Serum hK2 Levels and Predict the Presence of Prostate Cancer at Biopsy. Clin. Cancer Res., November 1, 2006; 12(21): 6452 - 6458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cheng, K. L. Penney, D. O. Stram, L. Le Marchand, E. Giorgi, C. A. Haiman, L. N. Kolonel, M. Pike, J. Hirschhorn, B. E. Henderson, et al. Haplotype-Based Association Studies of IGFBP1 and IGFBP3 with Prostate and Breast Cancer Risk: The Multiethnic Cohort. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1993 - 1997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cheng, D. O. Stram, K. L. Penney, M. Pike, L. Le Marchand, L. N. Kolonel, J. Hirschhorn, D. Altshuler, B. E. Henderson, and M. L. Freedman Common Genetic Variation in IGF1 and Prostate Cancer Risk in the Multiethnic Cohort J Natl Cancer Inst, January 18, 2006; 98(2): 123 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Nam, W. W. Zhang, M. A.S. Jewett, J. Trachtenberg, L. H. Klotz, M. Emami, L. Sugar, J. Sweet, A. Toi, and S. A. Narod The Use of Genetic Markers to Determine Risk for Prostate Cancer at Prostate Biopsy Clin. Cancer Res., December 1, 2005; 11(23): 8391 - 8397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ntais, A. Polycarpou, and J. P.A. Ioannidis Association of GSTM1, GSTT1, and GSTP1 Gene Polymorphisms with the Risk of Prostate Cancer: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 176 - 181. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
